Time to deterioration as measure for symptom burden and quality of life – Data from the LuLife project in 507 patients with non-small cell lung cancer in Germany.

von Verschuer, U., Sandner, R., Tessen, H.-W., Emde, T.-O., Schnitzler, M., Binninger, A., Jänicke, M., Marschner, N., 2016.

Oncol Res Treat 39 (suppl 3)(V986), 303. doi:10.1159/000449050

Studie: TLK; Indikation: Bronchialkarzinom; Jahr: 2016; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com